249 related articles for article (PubMed ID: 21250971)
1. Optimal management of β thalassaemia intermedia.
Taher AT; Musallam KM; Cappellini MD; Weatherall DJ
Br J Haematol; 2011 Mar; 152(5):512-23. PubMed ID: 21250971
[TBL] [Abstract][Full Text] [Related]
2. Insight onto the pathophysiology and clinical complications of thalassemia intermedia.
Cappellini MD; Musallam KM; Taher AT
Hemoglobin; 2009; 33 Suppl 1():S145-59. PubMed ID: 20001620
[TBL] [Abstract][Full Text] [Related]
3. Contemporary approaches to treatment of beta-thalassemia intermedia.
Taher AT; Musallam KM; Karimi M; Cappellini MD
Blood Rev; 2012 Apr; 26 Suppl 1():S24-7. PubMed ID: 22631038
[TBL] [Abstract][Full Text] [Related]
4. Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies.
Taher A; Hershko C; Cappellini MD
Br J Haematol; 2009 Dec; 147(5):634-40. PubMed ID: 19681884
[TBL] [Abstract][Full Text] [Related]
5. Revisiting beta thalassemia intermedia: past, present, and future prospects.
Ben Salah N; Bou-Fakhredin R; Mellouli F; Taher AT
Hematology; 2017 Dec; 22(10):607-616. PubMed ID: 28589785
[TBL] [Abstract][Full Text] [Related]
6. Australian guidelines for the assessment of iron overload and iron chelation in transfusion-dependent thalassaemia major, sickle cell disease and other congenital anaemias.
Ho PJ; Tay L; Lindeman R; Catley L; Bowden DK
Intern Med J; 2011 Jul; 41(7):516-24. PubMed ID: 21615659
[TBL] [Abstract][Full Text] [Related]
7. Modern treatment of thalassaemia intermedia.
Borgna-Pignatti C
Br J Haematol; 2007 Aug; 138(3):291-304. PubMed ID: 17565568
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for diagnosis and management of Beta-thalassemia intermedia.
Karimi M; Cohan N; De Sanctis V; Mallat NS; Taher A
Pediatr Hematol Oncol; 2014 Oct; 31(7):583-96. PubMed ID: 25247665
[TBL] [Abstract][Full Text] [Related]
9. [Current management of thalassemia intermedia].
Thuret I
Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
[TBL] [Abstract][Full Text] [Related]
10. The surgeon and the patient with β-thalassaemia intermedia.
Saad GS; Musallam KM; Taher AT
Br J Surg; 2011 Jun; 98(6):751-60. PubMed ID: 21480198
[TBL] [Abstract][Full Text] [Related]
11. Treatment strategies for hemoglobin E beta-thalassemia.
Olivieri NF
Blood Rev; 2012 Apr; 26 Suppl 1():S28-30. PubMed ID: 22631039
[TBL] [Abstract][Full Text] [Related]
12. Hb E beta +-thalassaemia in west Malaysia: clinical features in the most common beta-thalassaemia mutation of the Malays [IVS 1-5 (G-->C)].
George E; Wong HB
Singapore Med J; 1993 Dec; 34(6):500-3. PubMed ID: 8153710
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between available guidelines for the management of patients with beta-thalassemia major.
Musallam KM; Angastiniotis M; Eleftheriou A; Porter JB
Acta Haematol; 2013; 130(2):64-73. PubMed ID: 23485589
[TBL] [Abstract][Full Text] [Related]
14. Thalassemia intermedia: revisited.
Taher A; Isma'eel H; Cappellini MD
Blood Cells Mol Dis; 2006; 37(1):12-20. PubMed ID: 16737833
[TBL] [Abstract][Full Text] [Related]
15. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
[TBL] [Abstract][Full Text] [Related]
16. [Therapeuetic management of patients with thalassemia major].
Thuret I
Bull Soc Pathol Exot; 2001 May; 94(2):95-7. PubMed ID: 11475036
[TBL] [Abstract][Full Text] [Related]
17. Iron overload in β-thalassemia intermedia: an emerging concern.
Musallam KM; Cappellini MD; Taher AT
Curr Opin Hematol; 2013 May; 20(3):187-92. PubMed ID: 23426199
[TBL] [Abstract][Full Text] [Related]
18. Beta-thalassemia and the advent of new interventions beyond transfusion and iron chelation.
Chauhan W; Shoaib S; Fatma R; Zaka-Ur-Rab Z; Afzal M
Br J Clin Pharmacol; 2022 Aug; 88(8):3610-3626. PubMed ID: 35373382
[TBL] [Abstract][Full Text] [Related]
19. Common queries in thalassemia care.
Panigrahi I; Marwaha RK
Indian Pediatr; 2006 Jun; 43(6):513-8. PubMed ID: 16820660
[TBL] [Abstract][Full Text] [Related]
20. A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies?
Cappellini MD; Porter JB; Viprakasit V; Taher AT
Blood Rev; 2018 Jul; 32(4):300-311. PubMed ID: 29455932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
